The effect of subinhibitory concentrations of antibiotics on adherence of pseudomonas aeruginosa to cystic fibrosis (CF) and non-CF-affected tracheal epithelial cells

Journal of Infection

Volumn 37, Issue 3, 1998, Pages 217-223

  Wolter, J M ^a   McCormack, J G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM ADHERENCE; CYSTIC FIBROSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; TRACHEA MUCOSA;

EID: 0032418114     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)91859-X     Document Type: Article

References (22)

1. Govan JRW, Doherty C, Glass S. Rational parameters for antibiotic therapy in patients with cystic fibrosis. Infection 1987; 15: 300-307.
2. Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis 1985; 132: 761-765.
3. Bingen E, Denamur E, Picard B et al. Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1992; 11: 432-437.
4. Glass S, Hayward C, Govan JRW. Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis. J Paediatr 1988; 113: 76-79.
5. Wolter JM, Bowler SD, McCormack JG. Pseudomonas aeruginosa in cystic fibrosis - effect of MIC on clinical outcome, abstr. Aust NZ J Med 1997; 27: 258.
6. Smith AL. Antibiotic resistance is not relevant in infections in cystic fibrosis. Pediatr Pulmonol 1990; 9 (Suppl. 5): 93.
7. Watson AA, Mattick JS, Aim RA. Functional expression of heterologous type 4 fimbriae in Pseudomonas aeruginosa. Gene 1996; 175: 143-150.
8. Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR (ed). Manual of Clinical Microbiology. Washington DC: ASM Press, 1995, pp. 1327-1341.
9. Barry AL, Relier LB, Miller HG et al. Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. J Clin Microbiol 1992; 30: 585-589.
10. Yankaskas JR, Haizlip JE, Conrad M et al. Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. Am J Physiol 1993; 264: C1219-1230.
11. Saiman L, Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface on cystic fibrosis epithelial cells. J Clin Invest 1993; 92: 1875-1880.
12. Davies JC, Stern M, Dewar A et al. CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am J Resp Cell Mol Biol 1997; 16: 657-663.
13. De Bentzmann S, Roger P, Dupuit F et al. Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun 1996; 64: 1582-1588.
14. Pier GB, Grout M, Zaidi TS et al. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 1996; 271: 64-67.
15. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Nat Acad Sci USA 1997; 94: 12088-12093.
16. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
17. Goldman MJ, Anderson GM, Stolzenberg ED et al. Human beta-defensin-1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997; 88: 553-560.
18. Prince A. Adhesins and receptors of Pseudomonas aeruginosa ascnsociated with infection of the respiratory tract. Microb Pathog 1992; 13: 251-260.
19. Jacquot J, Puchelle E, Hinnrasky J et al. Localization of the cystic fibrosis transmembrane conductance regulator in airways secretory glands. Eur Resp J 1993; 6: 169-176.
20. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 1994; 93: 737-744.
21. Hanberger H, Svensson E, Nilsson LE, Nilsson M. Pharmacodynamic effects of meropenem on gram negative bacteria. Eur J Clin Microbiol Infect Dis 1995; 14: 383-390.
22. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338: 725-726.